Several studies have shown that the outcomes of patients with C11orf95-RELA fusion-positive ependymoma are worse than those of patients with the other two subtypes (Pajtler et al. 2015; Malgulwar et al. 2018; Wang et al. 2019). The gene discussed is RELA; the disease is ependymoma.